Suchergebnisse

59 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: Cisplatin, シスプラチン

• 2024, Rana JN, Mumtaz S, Han I, Ha Choi E
  Harnessing the synergy of nanosecond high-power microwave pulses and cisplatin to increase the induction of apoptosis in cancer cells through the activation of ATR/ATM and intrinsic pathways [med./bio.]
  Free Radic Biol Med 225: 221-235
• 2024, Woo SH, Jung BC, Kim JY, Lee YH, Kim YS
  PEMF Potentiates Doxorubicin-induced Late G2 Arrest in MDA-MB-231 Breast Cancer Cells [med./bio.]
  Anticancer Res 44 (7): 2837-2846
• 2024, Zafari J, Rastegar-Pouyani N, Javani Jouni F, Najjar N, Azarshin SZ, Jafarzadeh E, Abdolmaleki P, Hoseini Shirazi F
  Static magnetic field reduces cisplatin resistance via increasing apoptosis pathways and genotoxicity in cancer cell lines [med./bio.]
  Sci Rep 14: 5792
• 2023, Abdelrahman SA, Raafat N, Abdelaal GMM, Aal SMA
  Electric field-directed migration of mesenchymal stem cells enhances their therapeutic potential on cisplatin-induced acute nephrotoxicity in rats [med./bio.]
  Naunyn Schmiedebergs Arch Pharmacol 396 (6): 1077-1093
• 2022, Yu X, Ji X, Fan Y, Yu B, Wang X, Feng C, Zhang L, Song C, Zhang X
  Static Magnetic Fields Protect against Cisplatin-Induced Kidney Toxicity [med./bio.]
  Antioxidants 12 (1): 73
• 2022, Wolff CM, Bekeschus S
  Synergistic In Vitro Anticancer Toxicity of Pulsed Electric Fields and Glutathione [med./bio.]
  Int J Mol Sci 23 (23): 14772
• 2022, Tayebi-khorami M, Chegeni N, Tahmasbi Birgani M, Danyaei A, Fardid R, Zafari J
  Enhancement of Cisplatin Sensitivity by Microwave Radiation in Ovarian Cancer Cells [med./bio.]
  Pharm Sci 28 (2): 295-303
• 2022, Chen MY, Li J, Zhang N, Waldorff EI, Ryaby JT, Fedor P, Jia Y, Wang Y
  In Vitro and in Vivo Study of the Effect of Osteogenic Pulsed Electromagnetic Fields on Breast and Lung Cancer Cells [med./bio.]
  Technol Cancer Res Treat 21: 15330338221124658
• 2022, Shibaki R, Kakikawa M
  Different effects of magnetic field on drug activity in human uterine sarcoma cell lines MES-SA and MES-SA/Dx5 [med./bio.]
  Electromagn Biol Med 41 (3): 343-351
• 2022, Wang S, Huyan T, Lou C, Shang P, Zhang H
  12 T high static magnetic field suppresses osteosarcoma cells proliferation by regulating intracellular ROS and iron status [med./bio.]
  Exp Cell Res 417 (2): 113223
• 2021, Mumblat H, Martinez-Conde A, Braten O, Munster M, Dor-On E, Schneiderman RS, Porat Y, Voloshin T, Davidi S, Blatt R, Shteingauz A, Tempel-Brami C, Zeevi E, Lajterer C, Shmueli Y, Danilov S, Haber A, Giladi M, Weinberg U, Kinzel A, Palti Y
  Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models [med./bio.]
  Lung Cancer 160: 99-110
• 2020, Rageh MM, El-Garhy MR, Mohamad EA
  Magnetic fields enhance the anti-tumor efficacy of low dose cisplatin and reduce the nephrotoxicity [med. Anw.]
  Naunyn Schmiedebergs Arch Pharmacol 393 (8): 1475-1485
• 2020, Karanam NK, Ding L, Aroumougame A, Story MD
  Tumor treating fields cause replication stress and interfere with DNA replication fork maintenance: Implications for cancer therapy [med./bio.]
  Transl Res 217: 33-46
• 2019, Rageh MM, Mohamad EA, El-Garhy MR
  Magnetic Field Improves the Efficiency of Low Dose Cis-Platin by Alteration the Oxidative Stress in Ehrlich Carcinoma-Bearing Mice [med./bio.]
  Egypt Acad J Biol Sci B Zool 11 (3): 107-112
• 2019, Ceresoli GL, Aerts JG, Dziadziuszko R, Ramlau R, Cedres S, van Meerbeeck JP, Mencoboni M, Planchard D, Chella A, Crinò L, Krzakowski M, Rüssel J, Maconi A, Gianoncelli L, Grosso F
  Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial [med. Anw.]
  Lancet Oncol 20 (12): 1702-1709
• 2019, Michel O, Błasiak P, Saczko J, Kulbacka J, Drąg-Zalesińska M, Rzechonek A
  Electropermeabilization of metastatic chondrosarcoma cells from primary cell culture [med./bio.]
  Biotechnol Appl Biochem 66 (6): 945-954
• 2019, Jalali A, Zafari J, Jouni FJ, Abdolmaleki P, Shirazi FH, Khodayar MJ
  Combination of static magnetic field and cisplatin in order to reduce drug resistance in cancer cell lines [med./bio.]
  Int J Radiat Biol 95 (8): 1194-1201
• 2019, Kakikawa M, Maeda T, Yamada S
  Combined Effect of 60 Hz Magnetic Fields and Anticancer Drugs on Human Hepatoma HepG2 Cells [med./bio.]
  IEEE J Electromagn RF Microw Med Biol 3 (1): 56 - 60
• 2018, Le Renard PE, Nimmervoll B, Fellner F, Oppelt P
  Cisplatin in-vitro activity with co-exposure to MRI [med./bio.]
  2018 EMF-Med 1st World Conference on Biomedical Applications of Electromagnetic Fields (EMF-Med), Split, Croatia. IEEE: S. 1-2; ISBN 978-1-5386-5922-9
• 2018, Sanie-Jahromi F, Saadat M
  Effects of electromagnetic field, cisplatin and morphine on cytotoxicity and expression levels of DNA repair genes [med./bio.]
  Mol Biol Rep 45 (5): 807-814
• 2018, Yuan LQ, Wang C, Zhu K, Li HM, Gu WZ, Zhou DM, Lai JQ, Zhou D, Lv Y, Tofani S, Chen X
  The antitumor effect of static and extremely low frequency magnetic fields against nephroblastoma and neuroblastoma [med./bio.]
  Bioelectromagnetics 39 (5): 375-385
• 2018, Mahmoudinasab H, Saadat M
  Electromagnetic Field Could Protect SH-SY5Y Cells Against Cisplatin Cytotoxicity, But Not MCF-7 Cells [med./bio.]
  DNA Cell Biol 37 (4): 330-335
• 2018, Ryu J, Lee K, Joe C, Joo J, Lee N, Yoo HS
  Patient With Unresectable Cholangiocarcinoma Treated With Radiofrequency Hyperthermia in Combination With Chemotherapy: A Case Report [med. Anw.]
  Integr Cancer Ther 17 (2): 558-561
• 2017, Kamalipooya S, Abdolmaleki P, Salemi Z, Javani Jouni F, Zafari J, Soleimani H
  Simultaneous application of cisplatin and static magnetic field enhances oxidative stress in HeLa cell line [med./bio.]
  In Vitro Cell Dev Biol Anim 53 (9): 783-790
• 2017, Sanie-Jahromi F, Saadat M
  Different profiles of the mRNA levels of DNA repair genes in MCF-7 and SH-SY5Y cells after treatment with combination of cisplatin, 50-Hz electromagnetic field and bleomycin [med./bio.]
  Biomed Pharmacother 94: 564-568